CAS: 1211877-36-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | (R)-MG132 REF: IN-DA009BMJCAS: 1211877-36-9 | 98% | 37.00 €~574.00 € | Wed 04 Dec 24 |
 | (R)-MG-132 REF: TM-T12628CAS: 1211877-36-9 | 98.45% | 40.00 €~1,082.00 € | Wed 11 Dec 24 |
 | (R)-MG-132 REF: TR-M340975CAS: 1211877-36-9 | - - - | 10,915.00 € | Tue 14 Jan 25 |
 | (R)-MG 132 REF: 3D-LYB87736CAS: 1211877-36-9 | Min. 95% | To inquire | Wed 15 Jan 25 |
Ref: IN-DA009BMJ
| 1g | 574.00 € | ||
| 10mg | 37.00 € | ||
| 25mg | 53.00 € | ||
| 50mg | 76.00 € | ||
| 100mg | 101.00 € | ||
| 250mg | 184.00 € | ||
| 500mg | 239.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
(R)-MG-132
CAS:1211877-36-9
(R)-MG-132 (Z-Leu-D-leu-leu-al) is the enantiomer of MG-132. (R)-MG-132 stereoisomer is a more potent proteasome inhibitor …
Formula:
C26H41N3O5
Purity:
98.45%
Color and Shape:
Solid
Molecular weight:
475.62
Ref: TM-T12628
| 1g | 1,082.00 € | ||
| 2mg | 40.00 € | ||
| 5mg | 59.00 € | ||
| 10mg | 82.00 € | ||
| 25mg | 132.00 € | ||
| 50mg | 212.00 € | ||
| 100mg | 325.00 € | ||
| 500mg | 779.00 € | ||
| 1mL*10mM (DMSO) | 77.00 € |
Estimated delivery in United States, on Wednesday 11 Dec 2024
(R)-MG-132
Controlled ProductCAS:1211877-36-9
Formula:
C26H41N3O5
Color and Shape:
Neat
Molecular weight:
475.621
Ref: TR-M340975
| 250mg | 10,915.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
(R)-MG 132
CAS:1211877-36-9
Ischemia reperfusion injury is a major cause of irreversible brain damage. The enzyme GTPase-activating protein …
Formula:
C26H41N3O5
Purity:
Min. 95%
Molecular weight:
475.63 g/mol
Ref: 3D-LYB87736
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
